UNSPSC 51101669: Monensin

This classification denotes an antiprotozoal agent with the molecular formula C36H62O11, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 906O0YJ6ZP, chemically known as monensin, monosodium salt but generally known as monensin, which bears US NIH Compound Identifier 4243. European Medicines Agency schedules Monensin in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09048MIG.

UNSPSC 51101669 Monensin, a Commodity code, covers veterinary pharmaceuticals and feed additives that state and local governments procure for animal health, disease prevention, and livestock management programs. However, the recent opportunities tagged to this code show little alignment with monensin itself — the Illinois Department of Public Health awarded a $2,999,999.11 pharmaceutical warehouse piggyback contract through MMCAP Infuse to Chartwell Rx LLC for human antibiotics (Doxycycline Hyclate 100mg and Ciprofloxacin Hydrochloride 500mg), and Seminole County, Florida issued an IFB for naloxone and drug deactivation systems for community health initiatives. Neither opportunity involves monensin or veterinary pharmaceuticals, suggesting the code may be misapplied to these human-health and emergency-response procurements or reflects data-entry inconsistencies in the state and local procurement databases.

The available recent opportunities show activity from a state health department and a county public health authority, but neither represents typical monensin purchasing patterns. The Illinois opportunity, posted August 28, 2026, with a September 11, 2026 response deadline, was completed as an award rather than an open solicitation. Seminole County's naloxone procurement, posted June 30, 2026, with a July 26, 2023 deadline (an apparent date error in the source), sought 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries. Geographic spread across these records is limited to Illinois and Florida, and neither opportunity reflects demand for the feed additives or veterinary therapeutics that the code nominally describes. Firms pursuing monensin or related animal-health products under this code should monitor for misclassified opportunities or seek direct engagement with state and local departments of agriculture, veterinary boards, and livestock management agencies rather than rely on recent UNSPSC-tagged opportunities.